Leerink: Pharmacyclics Is Now Worth $240 By: Benzinga via Benzinga March 03, 2015 at 15:33 PM EST In a report published Monday, Leerink analysts Howard Liang and Gena Wang boosted their price target on Pharmacyclics, Inc. (NASDAQ: ... Read More >>